The Sarantis Group announces the addition of Stérimar to its Health & Care Division product portfolio from October 1, 2026, expanding its collaboration with Church & Dwight Co., Inc. and marking its entry into the nasal care category in the Greek pharmacy market.
According to the relevant press release, with 50 years of expertise in nasal care and a presence in more than 90 countries, Stérimar is an internationally recognized brand, with a history that began in France in 1975. For five decades, it has invested in scientific research and innovation, developing specialized nasal care solutions for the whole family, from infants to adults.
At the heart of Stérimar is 100% natural seawater from Cancale Bay in Brittany, France, naturally rich in mineral salts and trace elements. Combining natural origin, clinically proven effectiveness, and innovation, Stérimar offers specialized solutions for daily nasal hygiene and relief from nasal congestion, without steroids, drugs, or preservatives.
Four solutions for different needs
With the Greek pharmacy market at its core, Stérimar offers a comprehensive portfolio of four specialized solutions, designed for different ages and needs.
The range is developed along two main axes: Nasal Hygiene, for daily nose care, and blocked nose, for the relief of nasal congestion.
The portfolio includes Stérimar Nose Hygiene and Stérimar Blocked Nose for children and adults, as well as Stérimar Nose Hygiene Baby and Stérimar Blocked Nose Baby, specially designed for the needs of infants.
Innovation is a key element of Stérimar’s philosophy, with particular emphasis on infant care. The Stérimar Baby range features a patented safety nozzle, specially designed for small infant noses, offering gentle and safe application, adapted to their specific needs.
The addition of Stérimar to the Health & Care Division is another important step in the strategic development of the Sarantis Group in the Greek pharmacy market and in the expansion of its collaboration with Church & Dwight.
At the same time, it marks the Group’s entry into a new category, enriching its offering to pharmacies with an internationally recognized brand that combines natural origin, scientific substantiation, and innovation.
With the momentum and expertise of the Sarantis Group, Stérimar aims to strengthen its presence once again in the Greek market, building strong relationships with pharmacies and healthcare professionals and offering Greek families reliable and innovative solutions for daily nasal care.